awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51218322-B8B74F6D-5B4C-4ABC-903C-8D91DB82CB07
Q51218322-B8B74F6D-5B4C-4ABC-903C-8D91DB82CB07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51218322-B8B74F6D-5B4C-4ABC-903C-8D91DB82CB07
Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
P2860
Q51218322-B8B74F6D-5B4C-4ABC-903C-8D91DB82CB07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51218322-B8B74F6D-5B4C-4ABC-903C-8D91DB82CB07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c31ef5020b9c92d27c3d64583a5f7b379d84b0b9
P2860
Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.